Cizzle Biotech Make Breakthrough in Automating Test Results for Early Detection of Lung Cancer

Описание к видео Cizzle Biotech Make Breakthrough in Automating Test Results for Early Detection of Lung Cancer

Cizzle Biotech's CEO, Allan Syms, discusses the company's expansion of its research program in partnership with the University of York following a pivotal breakthrough in the commercialization of the testing process to a platform that automates the testing process.

The collaboration aims to develop biomarker technology (CIZ 1B) for early-stage cancer diagnosis, specifically targeting lung cancer.

By Mark Fairbairn

Комментарии

Информация по комментариям в разработке

Похожие видео